Lv1
30 积分 2025-01-20 加入
In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam
6天前
已完结
In vitro activity of imipenem/relebactam against Gram-negative clinical isolates in two Spanish tertiary hospitals
6天前
已关闭
Imipenem/cilastatin/relebactam: A new carbapenem β-lactamase inhibitor combination
8天前
已完结
Emerging resistance mechanisms to newer β-lactams in Pseudomonas aeruginosa
21天前
已完结
Neutrophil Lifespan Extension with CLON-G and an <em>In Vitro</em> Spontaneous Death Assay
25天前
已完结
New Delhi metallo-β-lactamase-producing Acinetobacter baumannii in the USA from October, 2013, to March, 2022: a retrospective molecular epidemiological analysis
1个月前
已完结
Therapeutic challenges in treating ESBL- and/or AmpC-producing non-carbapenemase-producing Enterobacterales : an in vitro evaluation of novel β-lactam/β-lactamase inhibitor combinations and cefiderocol
2个月前
已完结
Current Management Strategies of Difficult-to-Treat Resistant Pseudomonas aeruginosa Infections
2个月前
已关闭
Extended and Continuous Infusion of Novel Protected β-Lactam Antibiotics: A Narrative Review
2个月前
已完结
Emergence of transferable aztreonam-avibactam resistance in the high-risk ST44 subclade of carbapenemase-producing Providencia hangzhouensis, 2012–2023
3个月前
已完结
皖公网安备34019202002308
